Tesamorelin

Tesamorelin (Egrifta)

Strongfat_lossmetabolic

Community score3.50 reviews · 0 tracking

FDA-approved (Egrifta) for the reduction of visceral adipose tissue in HIV-associated lipodystrophy. A stabilized GHRH analog with a longer half-life than sermorelin. Off-label community interest centers on visceral fat reduction.

For research and personal log purposes. peptidio does not sell, ship, prescribe, or endorse any peptide for the prevention, treatment, or cure of any condition.